Pharmacological management of human respiratory syncytial virus infection.
Alexis M KalergisJorge A SotoNicolás M S GálvezCatalina A AndradeAyleen FernandezKaren BohmwaldSusan M BuenoPublished in: Expert opinion on pharmacotherapy (2020)
Today, many researchers are focused on developing different strategies to modulate the symptoms induced by hRSV. However, to achieve this, understanding how current treatments are working and their shortcomings needs to be further elucidated.